4.6 Review

Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions

期刊

CELLS
卷 11, 期 20, 页码 -

出版社

MDPI
DOI: 10.3390/cells11203237

关键词

IL-33; ST2; immune system; inflammation; alarmin; disease; organ transplantation

资金

  1. National Natural Science Foundation [31930041]
  2. National Key Research and Development Program of China [2017YFA0105002, 2017YFA0104402]
  3. Knowledge Innovation Program of the Chinese Academy of Sciences [XDA16030301]

向作者/读者索取更多资源

This article summarizes the role of IL-33 in regulating immune function and its association with various diseases. It emphasizes the context-dependent dual immune regulatory functions of IL-33 and its distinct roles in different cells.
Interleukin-33 (IL-33), a member of the IL-1 cytokine family and a multifunctional cytokine, plays critical roles in maintaining host homeostasis and in pathological conditions, such as allergy, infectious diseases, and cancer, by acting on multiple types of immune cells and promoting type 1 and 2 immune responses. IL-33 is rapidly released by immune and non-immune cells upon stimulation by stress, acting as an alarmin by binding to its receptor, suppression of tumorigenicity 2 (ST2), to trigger downstream signaling pathways and activate inflammatory and immune responses. It has been recognized that IL-33 displays dual-functioning immune regulatory effects in many diseases and has both pro- and anti-tumorigenic effects, likely depending on its primary target cells, IL-33/sST2 expression levels, cellular context, and the cytokine microenvironment. Herein, we summarize our current understanding of the biological functions of IL-33 and its roles in the pathogenesis of various conditions, including inflammatory and autoimmune diseases, infections, cancers, and cases of organ transplantation. We emphasize the nature of context-dependent dual immune regulatory functions of IL-33 in many cells and diseases and review systemic studies to understand the distinct roles of IL-33 in different cells, which is essential to the development of more effective diagnoses and therapeutic approaches for IL-33-related diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据